Rapidly Advancing New Scientific Discoveries to Transform the Way Cancer is Treated |
|
Using its proprietary delivery system, TransCode Therapeutics is developing targeted RNA therapeutics designed to target tumor cells and with its initial focus, tackle one of the most feared stages of cancer -- cancer progression or metastasis.
|
|
TransCode Therapeutics believes it has overcome the greatest barrier to harnessing RNA technology for cancer treatment — the targeting of RNA therapeutics to cancer cells
|
|
|
TransCode's lead therapeutic candidate TTX-MC138 has the potential to treat a variety of tumor indications that are known to become metastatic.
|
|
|
Power and Potential of RNA-based TherapiesThe power of RNA therapeutics lies in their ability to target any gene which enables rational and straightforward drug design. RNA-based therapeutics are highly selective to their targets, potentially making available a broad array of previously undruggable targets in cancer including metastasis.
|